Search Results - "SEO, Takayuki"

Refine Results
  1. 1

    Efficacy and Safety of Diclofenac–Hyaluronate Conjugate (Diclofenac Etalhyaluronate) for Knee Osteoarthritis: A Randomized Phase III Trial in Japan by Nishida, Yoshihiro, Kano, Kazuyuki, Nobuoka, Yuji, Seo, Takayuki

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-09-2021)
    “…Objective To confirm the efficacy and safety of intraarticular (IA) injection of diclofenac covalently linked to hyaluronic acid (diclofenac etalhyaluronate…”
    Get full text
    Journal Article
  2. 2

    Sustained-release diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate) for knee osteoarthritis: a randomized phase 2 study by Nishida, Yoshihiro, Kano, Kazuyuki, Nobuoka, Yuji, Seo, Takayuki

    Published in Rheumatology (Oxford, England) (02-03-2021)
    “…Abstract Objective To evaluate the efficacy and safety of diclofenac etalhyaluronate (DF-HA) (ONO-5704/SI-613), a novel DF-conjugated hyaluronate, in patients…”
    Get full text
    Journal Article
  3. 3

    Condoliase chemonucleolysis for lumbar disc herniation: A post-hoc follow-up study of patients in previous clinical trials by Matsuyama, Yukihiro, Seo, Takayuki, Chiba, Kazuhiro

    “…Chemonucleolysis with condoliase significantly improved clinical symptoms in patients with lumbar disc herniation. We evaluated the surgical intervention rate…”
    Get full text
    Journal Article
  4. 4

    Open-label phase 3 study of diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate: ONO-5704/SI-613) for treatment of osteoarthritis: 1-year follow-up by Nishida, Yoshihiro, Kano, Kazuyuki, Osato, Taiki, Seo, Takayuki

    Published in BMC musculoskeletal disorders (01-03-2021)
    “…We evaluated the 1-year safety and efficacy of diclofenac etalhyaluronate (DF-HA), a diclofenac-conjugated hyaluronate, in patients with osteoarthritis (OA)…”
    Get full text
    Journal Article
  5. 5

    Diclofenac-hyaluronate conjugate (diclofenac etalhyaluronate) intra-articular injection for hip, ankle, shoulder, and elbow osteoarthritis: a randomized controlled trial by Kubo, Toshikazu, Kumai, Tsukasa, Ikegami, Hiroyasu, Kano, Kazuyuki, Nishii, Megumi, Seo, Takayuki

    Published in BMC musculoskeletal disorders (20-04-2022)
    “…To evaluate the efficacy and safety of intra-articular injection of diclofenac etalhyaluronate (DF-HA) in patients with osteoarthritis (OA) of the hip, ankle,…”
    Get full text
    Journal Article
  6. 6

    Association between SCN1A polymorphism and carbamazepine‐resistant epilepsy by Abe, Tomohide, Seo, Takayuki, Ishitsu, Takateru, Nakagawa, Takehiro, Hori, Masaharu, Nakagawa, Kazuko

    Published in British journal of clinical pharmacology (01-08-2008)
    “…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The SCN1A gene encodes the α subunit of the neuronal voltage‐gated sodium channel, which is a target for…”
    Get full text
    Journal Article
  7. 7

    A Pooled Analysis of Two Multicenter, Randomized Controlled Trials of a Single Intra-articular Injection of Gel-200 for Treatment of Osteoarthritis of the Knee by Takamura, Junko, Seo, Takayuki, Strand, Vibeke

    “…Background and Objective: To perform an integrated analysis of 2 randomized controlled trials (RCTs) to assess the efficacy and safety of a single…”
    Get full text
    Journal Article
  8. 8

    Population Estimation Regarding the Effects of Cytochrome P450 2C19 and 3A5 Polymorphisms on Zonisamide Clearance by OKADA, Yusuke, SEO, Takayuki, ISHITSU, Takateru, WANIBUCHI, Atsuko, HASHIMOTO, Nami, HIGA, Yoko, NAKAGAWA, Kazuko

    Published in Therapeutic drug monitoring (01-08-2008)
    “…We aimed to evaluate the effects of cytochrome P450 (CYP) 2C19 and CYP3A5 polymorphisms on zonisamide (ZNS) clearance. The pharmacokinetics of the 282 ZNS…”
    Get full text
    Journal Article
  9. 9

    Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in japanese by GOTO, Shuji, SEO, Takayuki, MURATA, Tsukasa, NAKADA, Naoyuki, UEDA, Nao, ISHITSU, Takateru, NAKAGAWA, Kazuko

    Published in Therapeutic drug monitoring (01-02-2007)
    “…A nonlinear mixed-effect modeling (NONMEM) program was used to evaluate the effects of cytochrome P450 (CYP) 2C9 and CYP2C19 polymorphisms on the phenobarbital…”
    Get full text
    Journal Article
  10. 10

    Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers by Seo, Takayuki, Pahwa, Punam, McDuffie, Helen H, Yurube, Keigo, Egoshi, Masayoshi, Umemoto, Yuichiro, Ghosh, Sunita, Fukushima, Yumi, Nakagawa, Kazuko

    Published in Pharmacogenetics and genomics (01-06-2008)
    “…OBJECTIVEThe activity of the enzymes that metabolize tobacco smoke may affect the susceptibility to chronic obstructive pulmonary disease (COPD). Cytochrome…”
    Get full text
    Journal Article
  11. 11

    Interactive Effect of Paraoxonase-1 Q192R Polymorphism and Smoking History on the Lung Function Decline in Grain Workers by Seo, Takayuki, MS, Pahwa, Punam, PhD, McDuffie, Helen H., PhD, Nakada, Naoyuki, MS, Goto, Shuji, MS, Ghosh, Sunita, MS, Nakagawa, Kazuko, MD, PhD

    Published in Annals of epidemiology (01-04-2008)
    “…Purpose This retrospective longitudinal study investigated the association between the Q192R polymorphism of the high-density lipoprotein–associated…”
    Get full text
    Journal Article
  12. 12

    Impact of CYP2D610 on H1 -antihistamine -induced hypersomnia by SARUWATARI, Junji, MATSUNAGA, Masayuki, IKEDA, Kazuyuki, NAKAO, Masashi, ONIKI, Kentaro, SEO, Takayuki, MIHARA, Shuichi, MARUBAYASHI, Toru, KAMATAKI, Tetsuya, NAKAGAWA, Kazuko

    Published in European journal of clinical pharmacology (01-12-2006)
    “…This study investigated the relevance of the cytochrome P450 (CYP) 2D6 genotype to the adverse drug reactions (ADRs) of H1-antihistamines and the level of…”
    Get full text
    Journal Article
  13. 13

    Condoliase for the Treatment of Lumbar Disc Herniation: A Randomized Controlled Trial by Chiba, Kazuhiro, Matsuyama, Yukihiro, Seo, Takayuki, Toyama, Yoshiaki

    Published in Spine (Philadelphia, Pa. 1976) (01-08-2018)
    “…STUDY DESIGN.A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial. OBJECTIVE.To evaluate the efficacy and safety of…”
    Get full text
    Journal Article
  14. 14

    Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients by Goto, Shuji, Seo, Takayuki, Hagiwara, Takashi, Ueda, Kentaro, Yamauchi, Tsuyuko, Nagata, Shiro, Ando, Yukio, Ishitsu, Takateru, Nakagawa, Kazuko

    Published in Journal of pharmacy and pharmacology (01-02-2008)
    “…This study tested the hypothesis that the determinants of mild liver injury are prerequisites for more severe idiosyncratic hepatotoxicity. This study verified…”
    Get full text
    Journal Article
  15. 15

    A multicenter, randomized, double-blind, dose-finding study of condoliase in patients with lumbar disc herniation by Matsuyama, Yukihiro, Chiba, Kazuhiro, Iwata, Hisashi, Seo, Takayuki, Toyama, Yoshiaki

    Published in Journal of neurosurgery. Spine (01-05-2018)
    “…OBJECTIVE Chemonucleolysis with condoliase has the potential to be a new, less invasive therapeutic option for patients with lumbar disc herniation (LDH). The…”
    Get full text
    Journal Article
  16. 16

    Association between paraoxonase-1 Q192R polymorphism and lung function among Saskatchewan grain handlers by Takayuki, Seo, Pahwa, Punam, McDuffie, Helen H, Shindo, Junichi, Goto, Shuji, Hashimoto, Mirai, Ghosh, Sunita, Nakagawa, Kazuko

    Published in Pharmacogenomics (01-08-2007)
    “…Paraoxonase-1 (PON1) is a high-density, lipoprotein-associated, multifunctional antioxidant enzyme that is detected in nonciliated bronchiolar epithelial…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20